22 results · 23ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ORAL BALANCE LIQUID/ GEL

FDA 510(k)
FDA Unclassified ·Unknown

Spacelabs Healthcare

FDA UDI
SPACELABS HEALTHCARE (WASHINGTON), INC·10841522120275·ANT,608-614 MHZ, UDI

JP CAST 40

FDA 510(k)
FDA Class 2 ·Dental

SYNERGY HEAD/NECK COIL

FDA 510(k)
FDA Class 2 ·Radiology

STELLARIS VISION ENHANCEMENT SYSTEM

FDA Adverse Event
Injury ·BAUSCH + LOMB·Product code HQC·February 5, 2026

RU NOVOSIBIRSK

FDA Adverse Event
Other ·SORIN GROUP ITALIA·Product code DTZ·October 16, 2013

ST JOSEPHS PHOENIX, AZ 1

FDA Adverse Event
Malfunction ·SORIN GROUP USA·Product code DWF·July 31, 2009

RU NOVOSIBRIRSK

FDA Adverse Event
Other ·SORIN GROUP ITALIA·Product code DTZ·April 11, 2013

STELLARIS ELITE VISION ENHANCEMENT SYSTEM

FDA Adverse Event
Injury ·BAUSCH + LOMB·Product code HQC·March 1, 2022

RU NOVOSIBIRSK

FDA Adverse Event
Other ·SORIN GROUP ITALIA·Product code DWF·October 16, 2013

CP87170 DE MUENCHEN

FDA Adverse Event
Death ·SORIN GROUP ITALIA·Product code DTZ·July 15, 2011

GOBED II MED/SURG BED

FDA Adverse Event
Malfunction ·STRYKER MEDICAL-KALAMAZOO·Product code FNL·April 16, 2013

SPEEDBAND SUPERVIEW SUPER 7, MODELS 4204

FDA Adverse Event
Malfunction ·BOSTON SCIENTIFIC - SPENCER·Product code MND·April 18, 2011

UNK

FDA Adverse Event
Injury ·UNK·Product code FGE·June 13, 2008

CP87641 GB SOUTHAMPTON

FDA Adverse Event
Malfunction ·SORIN GROUP ITALIA·Product code DWE·March 22, 2010

STELLARIS POWER SUPPLY II

FDA Adverse Event
Malfunction ·BAUSCH + LOMB·Product code HQC·August 1, 2023

D 100 PH.I.S.I.O. NEWBORN HOLLOW FIBER MEMBRANE OXYGENATOR WITH RESERVOIR

FDA Adverse Event
Malfunction ·SORIN GROUP ITALIA S.R.L.·Product code DTZ·March 28, 2017

LOGIC TIBIA PS MOD INSRT SZ 6 11MM

FDA Adverse Event
Injury ·EXACTECH, INC.·Product code JWH·November 13, 2023

Brand Name: ¿ cobas c 6000 MODULAR Series System e 601 ¿ cobas c 8000 MODULAR Series System - e 602 ¿ Roche / Hitachi MODULAR Analytics Combination System Model/Catalog/Part Number: MODULAR Analytics E 170 ¿ 03022109001 ¿ 03023109973 ¿ 03739040001 ¿ 03739040692 ¿ 05023572001 ¿ 05023599001 cobas e 601 module ¿ 04745922001 ¿ 04745922692 ¿ 05036348001 ¿ 05036348692 ¿ 05860652001 cobas e 602 module ¿ 05990378001 The Roche/Hitachi MODULAR Analytics System (E170) is a fully automated, random-access, software- controlled system for immunoassay and photometric analysis intended for qualitative and quantitative in vitro determinations using a wide variety of tests. The cobas 6000 series (e 601) is a fully automated, random-access, software-controlled system for immunoassay and photometric analysis intended for qualitative and quantitative in vitro determinations using a wide variety of tests. It is optimized for high throughput workloads in the professional environment using a combination of Ion selective electrodes (ISE), a photometric analysis unit an immunoassay analysis module. The cobas 8000 Modular Analyze Series (e602) is a fully automated system for Clinical chemistry analysis, intended for the in vitro qualitative and quantitative determination of analytes in body fluids. It is optimized for high throughput workloads in the professional environment using a combination of ion selective electrodes (ISE) and a photometric analysis unit.

FDA Enforcement
Class II ·Terminated·Roche Diagnostics Corporation·January 24, 2018

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012